Long H Dang Selected Research

apratoxin S10

12/2017	Correction to "Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors".
10/2017	Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Long H Dang Research Topics

Disease

34	Neoplasms (Cancer) 01/2021 - 06/2002
9	Hypoxia (Hypoxemia) 10/2018 - 02/2006
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2002
6	Colonic Neoplasms (Colon Cancer) 08/2013 - 05/2003
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 07/2012
4	Disease Progression 01/2020 - 01/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2011
3	Carcinoma (Carcinomatosis) 10/2018 - 02/2011
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 05/2009
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2020
2	Infections 10/2018 - 01/2005
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 04/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Melanoma (Melanoma, Malignant) 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Vomiting 10/2018
1	Abdominal Pain (Pain, Abdominal) 10/2018
1	Gastritis 10/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2017
1	Small Cell Carcinoma 02/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016
1	Gangrene 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2015
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2013
1	Chondrosarcoma 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 09/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2009

Drug/Important Bio-Agent (IBA)

9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2006
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2003
4	Sunitinib (Sutent)FDA Link 01/2012 - 05/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 11/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2019
3	Bevacizumab (Avastin)FDA Link 01/2019 - 01/2011
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 02/2011
3	Transcription Factors (Transcription Factor)IBA 02/2011 - 02/2006
2	pembrolizumabIBA 01/2020 - 10/2018
2	apratoxin S10IBA 12/2017 - 10/2017
2	Messenger RNA (mRNA)IBA 07/2012 - 02/2011
1	Capecitabine (Xeloda)FDA Link 01/2021
1	apratoxin S4IBA 01/2021
1	AndrogensIBA 01/2021
1	PlatinumIBA 01/2020
1	dolastatin 15IBA 01/2020
1	TubulinIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2019
1	Anastrozole (Arimidex)FDA LinkGeneric 07/2019
1	Estrogen ReceptorsIBA 07/2019
1	1-methyl-1-piperidinomethane sulfonateIBA 04/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	ChemokinesIBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Small Interfering RNA (siRNA)IBA 10/2018
1	Thiamine (Aneurin)FDA Link 10/2018
1	AntibodiesIBA 10/2018
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2018
1	atezolizumabIBA 10/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2017
1	tyrosine receptor (receptor, tyrosine)IBA 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017
1	ras ProteinsIBA 01/2016
1	ibrutinibIBA 01/2016
1	caldoramideIBA 01/2016
1	Diphtheria ToxinIBA 01/2015
1	Interleukin-2 (IL2)IBA 01/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2015
1	denileukin diftitox (Ontak)FDA Link 01/2015
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2013
1	Versicans (Versican)IBA 11/2013
1	Factor V (Coagulation Factor V)IBA 08/2013
1	lysophosphatidic acidIBA 08/2013
1	Monoclonal AntibodiesIBA 05/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2013
1	Protons (Proton)IBA 01/2012
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 02/2011
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2011
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	pazopanib FDA Link 01/2011
1	Adenosine Triphosphate (ATP)IBA 11/2010
1	ErbB Receptors (EGF Receptor)IBA 11/2010
1	Thrombospondin 1IBA 05/2009
1	Angiopoietin-Like Protein 4IBA 05/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2009
1	Blood Proteins (Serum Proteins)IBA 03/2008

Therapy/Procedure

16	Therapeutics 01/2021 - 10/2004
7	Drug Therapy (Chemotherapy) 01/2020 - 01/2011
5	Radiotherapy 01/2018 - 12/2003
1	Castration 01/2018
1	Induction Chemotherapy 02/2016
1	Nephrectomy 01/2015